立即開始
Innoviva, Inc.
看多

Inva Buyout

由Leonardi007提供
Inva has activist Alex Denner in control of the board(5/5) and management which has been cut down to 2 people, includes CEO who is also Sarissa Executive. GSK has 30% ownership and probably will be likely buyer, they must have been waiting on Asthma indication approval which came earlier this month.
Beyond Technical AnalysisbuyoutbuyoutsFundamental AnalysisInverse Head and ShouldersTrend Analysis
Leonardi007
更多:

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。